preprint · ChemRxiv
Rhenium(I) tricarbonyl complexes in their monometallic forms have been extensively studied, mainly for their potent inhibitory activity against cancer cells. In this study, we report the synthesis, photoluminescence, crystal structure, and in vitro biological screening of five (5) ligands and their corresponding metal complexes. Of the five ligands, three crystal structures were analysed (with one being an oxidized ligand), while four metal complexes were studied. All crystallized in the monoclinic crystal system. The ligands and complexes, under the Beer-Lambert concentration range, displayed tuneable luminescent properties, with emission energies influenced by the electronic nature of the substituents on the backbone of the Schiff Base ligands. The in vitro cytotoxicity of selected compounds was tested against a panel of human cancer cell lines, including pancreatic (PANC-1, CFPAC-1), breast (MCF7, MDA-MB-231), and cervical (CaSki, HeLa) cancers. While most compounds showed moderate activity, complexes Re-2 and Re-3 exhibited interesting cytotoxicity against MCF7 and MDA-MB-231 cells, with IC50 values of 11.42 and 12.07 μM, respectively.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.26434/chemrxiv.15008197/v1
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.